Uncharacterized Protein, Uncharacterized
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 6 |
| NetGPI | no | yes: 0, no: 6 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 1 |
| GO:0005930 | axoneme | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HTV0
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 127 | 131 | PF00656 | 0.383 |
| CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.503 |
| CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.503 |
| CLV_PCSK_SKI1_1 | 148 | 152 | PF00082 | 0.476 |
| CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.369 |
| CLV_PCSK_SKI1_1 | 47 | 51 | PF00082 | 0.490 |
| DEG_SPOP_SBC_1 | 180 | 184 | PF00917 | 0.304 |
| DOC_CDC14_PxL_1 | 150 | 158 | PF14671 | 0.304 |
| DOC_CYCLIN_RxL_1 | 164 | 173 | PF00134 | 0.325 |
| DOC_CYCLIN_RxL_1 | 44 | 54 | PF00134 | 0.475 |
| DOC_MAPK_MEF2A_6 | 195 | 204 | PF00069 | 0.284 |
| DOC_PP4_FxxP_1 | 151 | 154 | PF00568 | 0.359 |
| DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.633 |
| DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.366 |
| DOC_USP7_MATH_1 | 6 | 10 | PF00917 | 0.594 |
| LIG_14-3-3_CanoR_1 | 195 | 204 | PF00244 | 0.417 |
| LIG_14-3-3_CanoR_1 | 22 | 31 | PF00244 | 0.528 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.681 |
| LIG_BIR_III_4 | 130 | 134 | PF00653 | 0.379 |
| LIG_eIF4E_1 | 197 | 203 | PF01652 | 0.325 |
| LIG_EVH1_2 | 154 | 158 | PF00568 | 0.304 |
| LIG_FHA_1 | 181 | 187 | PF00498 | 0.451 |
| LIG_FHA_2 | 22 | 28 | PF00498 | 0.568 |
| LIG_Pex14_2 | 145 | 149 | PF04695 | 0.475 |
| LIG_Pex14_2 | 158 | 162 | PF04695 | 0.304 |
| LIG_SH2_CRK | 197 | 201 | PF00017 | 0.304 |
| LIG_SH2_STAP1 | 197 | 201 | PF00017 | 0.284 |
| LIG_SH2_STAT3 | 191 | 194 | PF00017 | 0.325 |
| LIG_SUMO_SIM_anti_2 | 198 | 206 | PF11976 | 0.284 |
| LIG_SUMO_SIM_par_1 | 200 | 206 | PF11976 | 0.325 |
| LIG_TRAF2_1 | 58 | 61 | PF00917 | 0.466 |
| MOD_CK1_1 | 21 | 27 | PF00069 | 0.653 |
| MOD_CK2_1 | 21 | 27 | PF00069 | 0.581 |
| MOD_CK2_1 | 38 | 44 | PF00069 | 0.382 |
| MOD_CK2_1 | 55 | 61 | PF00069 | 0.494 |
| MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.499 |
| MOD_GlcNHglycan | 197 | 200 | PF01048 | 0.351 |
| MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.448 |
| MOD_GSK3_1 | 1 | 8 | PF00069 | 0.675 |
| MOD_GSK3_1 | 18 | 25 | PF00069 | 0.489 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.727 |
| MOD_NEK2_1 | 202 | 207 | PF00069 | 0.494 |
| MOD_PKA_2 | 21 | 27 | PF00069 | 0.552 |
| TRG_DiLeu_BaEn_1 | 52 | 57 | PF01217 | 0.504 |
| TRG_DiLeu_BaEn_3 | 165 | 171 | PF01217 | 0.278 |
| TRG_DiLeu_BaEn_4 | 60 | 66 | PF01217 | 0.441 |
| TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.494 |
| TRG_ENDOCYTIC_2 | 197 | 200 | PF00928 | 0.304 |
| TRG_ER_diArg_1 | 67 | 69 | PF00400 | 0.503 |
| TRG_Pf-PMV_PEXEL_1 | 169 | 173 | PF00026 | 0.325 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PCZ4 | Leptomonas seymouri | 53% | 88% |
| A0A3S7WQK8 | Leishmania donovani | 100% | 100% |
| A4H5L1 | Leishmania braziliensis | 78% | 100% |
| E9AMN7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
| Q4QHY8 | Leishmania major | 95% | 100% |